COMP <GO>
OPRX vs AMZN // GROSS PROFIT MARGIN
OptimizeRx Corporation (NASDAQ) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: OPRX 4
— AMZN 4
■ METRIC PARITY
LAST: $9.32 (-0.53%) • MKT CAP: $176.5M
gross-margins
67.30%
LAST: $240.35 (-1.41%) • MKT CAP: $2.63T
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OPRX VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OPRX | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 67.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.30% | 17.61% | -10.31 | AMZN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.9x | 15.8x | -0.85 | OPRX | /valuation <GO> |
| Free Cash Flow Yield | 10.57% | -1.81% | +12.38 | OPRX | /fcf-yield <GO> |
| Operating Margin | 10.70% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 4.70% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 18.80% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.68 | 3.32 | -0.64 | AMZN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 6/9 | +3.00 | OPRX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.73% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.3 | 47.2 | +17.10 | OPRX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.46 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.9x | 21.7x | +7.22 | AMZN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $176.5M | $2.63T | -$2.63T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OPRX REV | AMZN REV | OPRX GROSS % | AMZN GROSS % | OPRX FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $109.4M | $0 | 67.3% | — | $18.7M | $10.56B |
| FY 2024 | $92.1M | $0 | 64.5% | — | $4.8M | $42.95B |
| FY 2023 | $71.5M | $0 | — | — | -$7.2M | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OPRX // BETA —
AMZN // BETA 1.46